Aldeyra Therapeutics
- Pharmaceutical Preparations
- Lexington, Massachusetts
Compensation history
Top executives at Aldeyra Therapeutics received an average of $2M per person in annual compensation from 2015 to 2023.
Average pay of disclosed executives at Aldeyra Therapeutics
By year
Executives
We found eight executives who work or worked at Aldeyra Therapeutics.
Todd Brady
Aldeyra Therapeutics
Chief Executive Officer
Stephen Machatha
Aldeyra Therapeutics
Chief Development Officer
Bruce Greenberg
Aldeyra Therapeutics
Chief Financial Officer
Joshua Reed
Aldeyra Therapeutics
Chief Financial Officer
David Clark
Aldeyra Therapeutics
Chief Medical Officer
David McMullin
Aldeyra Therapeutics
Chief Commercial Officer
Stephen Tulipano
Aldeyra Therapeutics
Chief Financial Officer
Scott Young
Aldeyra Therapeutics
Chief Operating Officer
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019
About Aldeyra Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address131 Hartwell Avenue, Suite 320, Lexington, Massachusetts 02421
- Phone781-761-4904
- Fiscal year endDecember 31
- Former names
- Aldexa Therapeutics, Inc.Until March 3, 2014
- Neuron Systems IncUntil July 31, 2008
Source: SEC filings on April 22, 2024, May 23, 2023, April 25, 2022, April 27, 2020, April 22, 2019, April 25, 2018, and April 24, 2017.